(As of 8/31/2017)

Next Edge Bio-Tech Plus Fund Class F

(Alternative Strategies)
Inception Return
(1/21/2015)
0.63 %
YTD Return 7.12 %
NAVPS
(9/20/2017)
$10.52
Change $0.08 / 0.78 %
Growth of $10,000 (As of August 31, 2017)
MER -
Assets ($mil) -
Rank (1Yr) -
Std Dev (3Yr) -
Volatility Ranking (3Yr) -
RRSP Eligibility Yes
Load No Load
Max Front End -
Max Back End -
Sales Status Open
 
Objective
This Fund will seek short and long-term capital appreciation through the ownership of small and mid-capitalization biotechnology and healthcare companies based in Canada and the United States.
Management Co.
Next Edge Capital Corp.
Managers
 
Allocations
Data not available
Top 10 Holdings
Data not available

Performance Data (As of August 31, 2017)
  Return (%) Annualized Return (%)
Return 1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr
Fund 1.64 -2.47 -6.02 7.12 11.19 -    -    -   
Benchmark 0.67 -0.15 0.28 1.35 7.23 2.10 8.14 4.10
Quartile Ranking - - - - - - - -

Calendar Return (%) 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Fund -8.88 -      -      -      -      -      -      -      -      -     
Benchmark 21.08 -8.32 10.55 12.99 7.19 -8.71 17.61 35.06 -33.00 9.83
Quartile Ranking - - - - - - - - - -

Website powered by © Fundata Canada Inc.
Mutual Fund Data provided by Fundata. | View Terms and Conditions of Use .
BofA Merill Lynch Indices used with permission.
© 2014 Fundata Canada Inc. All rights reserved. | View Privacy Policy | Contact Us .